Page last updated: 2024-10-25

dantrolene and Autosomal Dominant Cerebellar Ataxia, Type II

dantrolene has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 1 studies

Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, J1
Tang, TS1
Tu, H1
Nelson, O1
Herndon, E1
Huynh, DP1
Pulst, SM1
Bezprozvanny, I1

Other Studies

1 other study available for dantrolene and Autosomal Dominant Cerebellar Ataxia, Type II

ArticleYear
Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009, Jul-22, Volume: 29, Issue:29

    Topics: Animals; Ataxins; Calcium; Calcium Channel Blockers; Calcium Signaling; Cell Death; Cells, Cultured;

2009